Intelligent Bio Solutions 

$2.75
43
-$0.37-11.86% Thursday 20:00

Statistics

Day High
2.89
Day Low
2.56
52W High
24.9
52W Low
2.56
Volume
1,118,671
Avg. Volume
624,716
Mkt Cap
4.41M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-1.5
-0.53
0.43
1.4
Expected EPS
1.4
Actual EPS
N/A

Financials

-346.18%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
6.11MRevenue
-21.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow INBS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a broad range of services and products for research, analysis, discovery, and diagnostics, directly competing with INBS's offerings in the biotech and healthcare solutions space.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation operates in the life sciences, diagnostics, and environmental industries, offering similar products and technologies that compete with INBS's portfolio.
Illumina
ILMN
Mkt Cap18.99B
Illumina, Inc. specializes in DNA sequencing and array-based technologies, competing with INBS in the genomic analysis and diagnostics sectors.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. provides a variety of instruments and reagents for research and clinical diagnostic applications, directly competing with INBS in the life sciences and healthcare market.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies, Inc. offers instruments, services, consumables, applications, and expertise, competing with INBS in areas such as diagnostics and genomics.
Waters
WAT
Mkt Cap20.81B
Waters Corporation produces analytical standards and instruments, including for chromatography and mass spectrometry, competing with INBS in the analytical and diagnostics sectors.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation designs and manufactures scientific instruments and analytical and diagnostic solutions, competing with INBS in providing comprehensive solutions for the biotech industry.
Guardant Health
GH
Mkt Cap11.72B
Qiagen NV
QGEN
Mkt Cap10.16B
QIAGEN N.V. offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing with INBS in the field of molecular diagnostics and research.

About

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Show more...
CEO
Mr. Harry Simeonidis
Employees
50
Country
US
ISIN
US36151G7097

Listings

0 Comments

Share your thoughts

FAQ

What is Intelligent Bio Solutions stock price today?
The current price of INBS is $2.75 USD — it has decreased by -11.86% in the past 24 hours. Watch Intelligent Bio Solutions stock price performance more closely on the chart.
What is Intelligent Bio Solutions stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Intelligent Bio Solutions stocks are traded under the ticker INBS.
Is Intelligent Bio Solutions stock price growing?
INBS stock has fallen by -14.6% compared to the previous week, the month change is a -37.36% fall, over the last year Intelligent Bio Solutions has showed a -79.63% decrease.
What is Intelligent Bio Solutions market cap?
Today Intelligent Bio Solutions has the market capitalization of 4.41M
When is the next Intelligent Bio Solutions earnings date?
Intelligent Bio Solutions is going to release the next earnings report on May 13, 2026.
What is Intelligent Bio Solutions revenue for the last year?
Intelligent Bio Solutions revenue for the last year amounts to 6.11M USD.
What is Intelligent Bio Solutions net income for the last year?
INBS net income for the last year is -21.14M USD.
How many employees does Intelligent Bio Solutions have?
As of April 04, 2026, the company has 50 employees.
In which sector is Intelligent Bio Solutions located?
Intelligent Bio Solutions operates in the Health Care sector.
When did Intelligent Bio Solutions complete a stock split?
The last stock split for Intelligent Bio Solutions was on December 16, 2025 with a ratio of 1:10.
Where is Intelligent Bio Solutions headquartered?
Intelligent Bio Solutions is headquartered in New York, US.